Synergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll‐Like Receptor Agonists and Is Blocked by Hemopexin
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Detection of microbial components by immune cells via Toll-like receptors (TLRs) with subsequent induction of inflammation is essential for host defense. However, an overactive immune response can cause tissue damage and sepsis. The endogenous molecule hemoglobin and its derivative heme are often released into tissue compartments where there is infection in the presence of degrading blood. We found that hemoglobin synergizes with multiple TLR agonists to induce high levels of tumor necrosis factor and interleukin-6 from macrophages and that this synergy is independent of TLR4 and MyD88. In contrast, heme synergized with some but not all TLR agonists studied. Furthermore, the synergy of both hemoglobin and heme with lipopolysaccharide was suppressed by hemopexin, a plasma heme-binding protein. These studies suggest that hemoglobin and heme may substantially contribute to microbe-induced inflammation when bacterial or viral infection coexists with blood degradation and that hemopexin may play a role in controlling inflammation in such settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Generation of free hemoglobin complexes with LPS result in enhanced biological activity, and free hemoglobin and heme act synergistically at various Toll-like receptors [27-29].”
From Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome (2012) · cites this paper as [29]
Experimental — accuracy not yet measuredIn the citing paper
“As stated above, however, there is ample evidence for a causal relationship between free hemoglobin and outcome of sepsis in animal models: free hemoglobin affects Toll-like receptor signal transduction, TNFα generation and mortality [6,29,35].”
From Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome (2012) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198 · cited 1×
“flammation in the setting of infection [3], is charac-”
BackgroundPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 7×
“Strong synergy of hemoglobin with TLR2, TLR3, TLR4, TLR7, and TLR9 agonists and with bacteria to induce TNF and IL6 from macrophages.”
InfluentialTakeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777 · cited 7×
“Strong synergy of hemoglobin with TLR2, TLR3, TLR4, TLR7, and TLR9 agonists and with bacteria to induce TNF and IL6 from macrophages.”
InfluentialCurrent Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328 · cited 1×
“To our knowledge, this is the first study to systematically evaluate the synergy of native hemoglobin on inflammation induced by multiple TLR agonists, including ligands for TLR3, TLR7, and TLR9, which are involved in inducing inflammation after viral infections [38, 39], to report synergy of TLR agonists with heme an…”
BackgroundUnresponsiveness of MyD88-Deficient Mice to Endotoxin
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,076 · cited 1×
“MyD88 knockout (MyD88 / ) mice were generated by Kawai and colleagues [25] and had been backcrossed 110 generations into the C57BL/6J strain.”
MethodPneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico
Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quiñones-Falconi, F., Bautista, E., Ramirez-Venegas, A., Rojas-Serrano, J., Ormsby, C. E., Corrales, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904252 · Cited by 1,325 · cited 1×
“The latter is of special relevance given the current epidemic of H1N1 influenza and the knowledge that severe disease can be accompanied by blood in the alveolar spaces [49].”
BackgroundHarmful molecular mechanisms in sepsis
Rittirsch, D., Flierl, M. A., & Ward, P. A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2402 · Cited by 1,202 · cited 2×
“Recent studies suggest that endogenous host molecules also can act as TLR ligands and that molecules released or induced during tissue damage may contribute to the induction of inflammatory cytokines in sepsis [4].”
Background
Research works printed but not linked: 1
- [22]Su D Roth RI Levin J Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice Crit Care Med 1999 27 771 8 10321668
Cited by
Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., & Vercellotti, G. M. (2013) · Blood · doi:10.1182/blood-2012-11-451229 · Cited by 754
Heme on innate immunity and inflammation
Dutra, F. F., & Bozza, M. T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00115 · Cited by 351
“Interestingly, the synergism of heme with PAMPs regarding the production of TNF and IL-6 is also dependent on serum (Fernandez et al., 2010; Lin et al., 2010).”
BackgroundVinchi, F., Costa da Silva, M., Ingoglia, G., Petrillo, S., Brinkman, N., Zuercher, A., Cerwenka, A., Tolosano, E., & Muckenthaler, M. U. (2016) · Blood · doi:10.1182/blood-2015-08-663245 · Cited by 269
“These observations are in line with recent studies demonstrating antioxidant and anti-inflammatory properties of Hx,(5,6,66-68) as well as its ability to prevent heme-triggered TLR4 activation and TNFa production.(17,54) Thus, Hx treatment provides a clear advantage over pharmacologic approaches in that it combines an…”
Mechanisms of haemolysis-induced kidney injury
Van Avondt, K., Nur, E., & Zeerleder, S. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0181-0 · Cited by 204
The Conserved Scavenger Receptor Cysteine-Rich Superfamily in Therapy and Diagnosis
Martínez, V. G., Moestrup, S. K., Holmskov, U., Mollenhauer, J., & Lozano, F. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004523 · Cited by 188
“In a manner similar to that shown for Hp (Boretti et al., 2009) and hemopexin (Lin et al., 2010), exogenous administration of sCD163 could then enhance the clearing of free heme from the circulation and thus prevent the development of sepsis or improve its outcome.”
Background
Metadata
- Authors
- Lin, T., Kwak, Y. H., Sammy, F., He, P., Thundivalappil, S., Sun, G., Chao, W., & Warren, H. S.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Warren, H. Shaw
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-08-15
- Volume
- 202
- Issue
- 4
- Pages
- 624-632
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC2932749
- OpenAlex
- W2129894040
- Cited by
- 91
- References
- 51
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 12 · 2013: 5 · 2012: 5
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Shriners Hospitals for Children
- National Institutes of Health (AI059010)
- National Institute of General Medical Sciences (R01GM080906, R01GM097259, R01GM059694, GM 59694)
- National Institute of Allergy and Infectious Diseases (AI059010, R01AI059010)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- hemoglobin, heme, hemopexin, TLR agonists, lipopolysaccharide, inflammation, macrophages, TNF-α, interleukin-6, TLR4, MyD88, sepsis, bacterial infection, viral infection
- MeSH terms
- Animals, Bacterial Toxins, Blood, Cells, Cultured, Escherichia coli, Heme, Hemoglobins, Hemopexin, Humans, Inflammation, Lipopolysaccharides, Macrophages, Staphylococcus aureus, Cytokines, Toll-Like Receptors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll‐Like Receptor Agonists and Is Blocked by Hemopexin. https://app.cochat.ai/papers/10.1086/654929
- The paper
- Lin, T., Kwak, Y. H., Sammy, F., He, P., Thundivalappil, S., Sun, G., Chao, W., & Warren, H. S. (2010). Synergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll‐Like Receptor Agonists and Is Blocked by Hemopexin. The Journal of Infectious Diseases. https://doi.org/10.1086/654929
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.